Clinical trials
Irritable Bowel Syndrome trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
59 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 2 |
| 2008 | 3 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 5 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 4 |
| 2019 | 3 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 3 |
| 2024 | 8 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 40 |
| Unknown status | 8 |
| Terminated | 5 |
| Recruiting | 4 |
| Active, not recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Nottingham | 14 |
| GlaxoSmithKline | 4 |
| King's College London | 3 |
| Menarini Group | 3 |
| Eli Lilly and Company | 2 |
| Furiex Pharmaceuticals, Inc | 2 |
| Nottingham University Hospitals NHS Trust | 2 |
| Sheffield Teaching Hospitals NHS Foundation Trust | 2 |
| 4D pharma plc | 1 |
| AbbVie | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Irritable Bowel Syndrome | 59 |
| Diarrhea | 9 |
| Constipation | 4 |
| Gastrointestinal Diseases | 4 |
| Intestinal Diseases | 4 |
| Inflammatory Bowel Diseases | 3 |
| Abdominal Pain | 2 |
| Dyspepsia | 2 |
| Mucopolysaccharidosis IV | 2 |
| Campylobacter Infections | 1 |
Trials
Showing 1 to 25 of 59. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.